Kyoto Breast Cancer Research Network (KBCRN)

Day 1: Thursday 14th April

8:55  Opening Remarks

9:00  Itemised issues: Leading-edge Treatment and Diagnosis

Lecture:	A new approach for sentinel node biopsy using OSNA (One- Step Nucleic acid Amplification) method (Seigo Nakamura, Japan)
Lecture:	Boron neutron capture for breast cancer (Minoru Suzuki, Japan)
Lecture:	Current topics of positron emission tomography in breast cancer (Yuji Nakamoto, Japan)

Discussion:	Breast Reconstruction King-Jen Chang, Taiwan, Yasuhiro Tamaki, Japan

11:20  Lunch

12:20  Poster Viewing / Discussion

12:50  Session 1: Breast MRI

Lecture:	Current status and problems of preoperative breast MRI (Mitsuhiro Tozaki, Japan)

Lecture:	Evaluation of presurgical systemic therapy by breast MRI (Shotaro Kanao, Japan)

13:50  Afternoon Seminar: DCIS

Lecture:	Biology and management of duct carcinoma in situ (DCIS) (John F Forbes, Australia)

14:30  Session 2: Nomogram and DCIS

Presentation:	Development of a novel prediction model to predict axillary lymph node metastasis in patients with primary breast cancer (Masahiro Takada, Japan)

Lecture:	Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer (Roman Rouzier, France)

Lecture:	Predictors for the diagnosis upgrade after excision of DCIS, ADH, and papillary neoplasm diagnosed by core needle biopsy (Wonshik Han, Korea)

Keynote lecture:	Evaluating treatment trade-offs: The Q-TWiST method (Bernard F Cole, USA)

Discussion:	( Members of Session 2 )

16:45  Case Study:	Are there any ways to know pCR after neoadjuvant chemotherapy before surgery?

Case Presentation:	(Shinji Ohno, Japan)

Panel Discussion:	(John R Benson / UK, Soo-Jung Lee / Korea, Norikazu Masuda / Japan, Hidetaka Kawabata / Japan)

Day 2: Friday 15th April

8:15  Morning Seminar:	ICG fluorescence Navigation Method co-organised with Hamamatsu Photonics K.K.

Lecture:	ICG fluorescence navigation story 2 - application to breast cancer surgery- (Kazuhiko Yamagami, Japan)

9:00  Session 3: Sentinel Lymph Node Biopsy co-organised with Novartis Pharma K.K.

Lecture:	Sentinel lymph node biopsy challenges for the surgeon (Mehra Golshan, USA)

Lecture:	Is intra-operative node assessment essential in a modern breast practice? (John R Benson, UK)

Lecture:	Arm node preserving surgery during SLNB or axillary lymph node dissection (Soo-Jung Lee, Korea)

Lecture:	Ultrasound for axillary staging (Chiun-Sheng Huang, Taiwan)

Presentation:	Partial axillary lymph node dissection for N0 breast cancer (Keiichi Mise, Japan)

Discussion:	( Members of Session 3 )

12:15  Lunch

13:10  Afternoon Seminar:	Molecular Target Therapy co-organised with Chugai Pharmaceutical Co., Ltd. (Mark D Pegram, USA)

13:50  Session 4: Neoadjuvant Chemotherapy-1 co-organised with Pfizer Japan Inc.

Lecture:	Pathologic assessment of neoadjuvant chemotherapy in breast carcinoma (Hironobu Sasano, Japan)
Lecture:	Neoadjuvant Chemotherapy – a surgical perspective (John F R Robertson, UK)

15:00  Session 4: Neoadjuvant Chemotherapy-2 co-organised with Pfizer Japan Inc.

Lecture:	Molecular subtype of breast cancer using a microfluidic multiplexed immunohistochemistry platform (Eun-Sook Lee, Korea)
Lecture:	Optimal use and future perspective of neoadjuvant therapy in breast cancer (Louis W.C. Chow, Hong Kong)
Lecture:	American practice of neoadjuvant therapy (Eric P Winer, USA)

16:50  Evening Seminar co-organised with sanofi-aventis K.K.:

Prediction of pathological response – Experience from the German neoadjuvant trials
(Gunter von Minckwitz, Germany)

Day 3: Saturday 16th April

9:00  Session 5: Breast Cancer in Young Women

Special Lecture:	Current issues on breast-conserving treatment in younger breast cancer patients (Rodrigo Arriagada, Sweden)

Lecture:	Breast cancer in young women (Ann H Partridge, USA)

9:45  Consensus Session 1:	Axillary Diagnosis and Treatment, Breast Surgery, DCIS and Radiology Chair: John R Benson, UK

11:15  Light Meal

11:45  Consensus Session 2:	Post-Neoadjuvant Diagnosis, Nomogram and Breast Cancer in Young Women Chair: Eric P Winer, USA

13:15  Closing Remarks

13:30 - 15:00
Workshop co-organised with Genomic Health, Inc.
Eric P Winer, Ann H Partridge

(updated on 8th April, 2011)